Houston, Texas October 6, 2009 – London American Risk Specialists, Inc. is pleased to congratulate our mutual Chapman & Associates client, Global Solutions for Infectious Diseases (GSID) for its work in the development of a new HIV preventative vaccine. According to newspaper articles published by the Los Angeles Times and Dallas Morning News, GSID recently announced that their clinical trials of this HIV vaccine regimen has been shown to be safe and modestly effective in preventing HIV infection and may certainly lead to the next generation of vaccines for AIDS.
Global Solutions for Infectious Diseases, a non-profit organization, is dedicated to changing the world through the development of low-cost effective solutions for the prevention of infectious diseases such as AIDS.
For more information concerning this topic please feel free to contact Mike Mullens at London American Risk Specialists, Dallas, Texas. 214-373-3936 (ext 206) or email mmullens@londonamericantx.com
Again, our heartfelt congratulations to Global Solutions for Infections Diseases for their tireless efforts to help make the world a healthier place.
Topics London
Was this article valuable?
Here are more articles you may enjoy.
AI Savings Misses ‘Should Be Making Executives Uncomfortable,’ Bain Says 
Hedge Funds Are Expanding Desks Designed to Profit From Natural-Catastrophe Risk 
USAA Not Done With Dividends: Florida Reforms Prompt $500M Payout 
WR Berkley Founder and Executive Chairman Dies at 80 
